Multiple drug resistance in cancer therapySCHNEIDER, E; COWAN, K. H.Medical journal of Australia. 1994, Vol 160, Num 6, pp 371-373, issn 0025-729XArticle

A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamatesCOWAN, K. H; JOLIVET, J.The Journal of biological chemistry (Print). 1984, Vol 259, Num 17, pp 10793-10800, issn 0021-9258Article

Dose-intensive therapy for breast cancerO'SHAUGHNESSY, J. A; COWAN, K. H.JAMA, the journal of the American Medical Association. 1993, Vol 270, Num 17, pp 2089-2092, issn 0098-7484Article

Fazarabine : a report of response in a patient with multiply relapsed embryonal cell carcinomaJOHNSTON, P. G; KLEINER, D; COWAN, K. H et al.American journal of clinical oncology. 1993, Vol 16, Num 1, pp 34-37, issn 0277-3732Article

Multidrug resistanceMOSCOW, J. A; SCHNEIDER, E; COWAN, K. H et al.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 99-129, issn 0921-4410Article

Multidrug resistanceMOSCOW, J. A; COWAN, K. H.Cancer chemotherapy and biological response modifiers annual. 1991, Vol 12, pp 91-109, issn 0921-4410, 19 p.Article

Irradiation-induced G2/M checkpoint response requires ERK1/2 activationYAN, Y; BLACK, C. P; COWAN, K. H et al.Oncogene (Basingstoke). 2007, Vol 26, Num 32, pp 4689-4698, issn 0950-9232, 10 p.Article

Multidrug resistanceMOSCOW, J. A; SCHNEIDER, E; COWAN, K. H et al.Cancer chemotherapy and biological response modifiers annual. 1993, Vol 14, pp 98-117, issn 0921-4410Article

Posttranscriptional control of glutathione S-transferase π gene expression in human breast cancer cellsMORROW, C. S; CHIU, J; COWAN, K. H et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 15, pp 10544-10550, issn 0021-9258Article

Multidrug resistance associated with altered topoisomerase II activity : topoisomerases II as targets for rational drug designMORROW, C. S; COWAN, K. H.Journal of the National Cancer Institute. 1990, Vol 82, Num 8, pp 638-639, issn 0027-8874Article

Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequencesGOLDSMITH, M. E; COWAN, K. H.Molecular pharmacology. 1988, Vol 33, Num 4, pp 378-383, issn 0026-895XArticle

In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenograftsKAIMEI SONG; COWAN, K. H; SINHA, B. K et al.Oncology research. 1999, Vol 11, Num 3, pp 153-159, issn 0965-0407Article

Current status of paclitaxel in the treatment of breast cancerO'SHAUGHNESSY, J. A; COWAN, K. H.Breast cancer research and treatment. 1995, Vol 33, Num 1, pp 27-37, issn 0167-6806Conference Paper

Multidrug resistanceMOSCOW, J. A; COWAN, K. H.Journal of the National Cancer Institute. 1988, Vol 80, Num 1, pp 14-20, issn 0027-8874Article

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancerCONLEY, B; O'SHAUGHNESSY, J; GOLDSPIEL, B et al.Journal of clinical oncology. 2000, Vol 18, Num 2, pp 275-283, issn 0732-183XArticle

Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor modelLI, Z; RAKKAR, A; KATAYOSE, Y et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 5, pp 605-613, issn 0969-7128Article

Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell lineGONG, M; YESS, J; CONNOLLY, T et al.Blood. 1997, Vol 89, Num 7, pp 2494-2499, issn 0006-4971Article

Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomasKAIMEI SONG; ZHUANGWU LI; SETH, P et al.Oncology research. 1997, Vol 9, Num 11-12, pp 603-609, issn 0965-0407Article

Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancerFISHERMAN, J. S; COWAN, K. H; CHOW, C et al.Journal of clinical oncology. 1996, Vol 14, Num 3, pp 774-782, issn 0732-183XArticle

Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy : a report of two casesTOLCHER, A. W; GIUSTI, R. M; O'SHAUGHNESSY, J. A et al.Cancer investigation. 1995, Vol 13, Num 2, pp 188-192, issn 0735-7907Article

Hormone-dependent regulation of BRCA1 in human breast cancer cellsGUDAS, J. M; HOANG NGUYEN; TAO LI et al.Cancer research (Baltimore). 1995, Vol 55, Num 20, pp 4561-4565, issn 0008-5472Article

Effects of a recombinant adenovius expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosisKATAYOSE, D; WERSTO, R; COWAN, K. H et al.Cell growth and differentiation. 1995, Vol 6, Num 10, pp 1207-1212, issn 1044-9523Article

The effect of systemic therapy on local-regional control in locally advanced breast cancerPIERCE, L. J; LIPPMAN, M; NOA BEN-BARUCH et al.International journal of radiation oncology, biology, physics. 1992, Vol 23, Num 5, pp 949-960, issn 0360-3016Article

Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumorsMOSCOW, J. A; FAIRCHILD, C. R; MADDEN, M. J et al.Cancer research (Baltimore). 1989, Vol 49, Num 6, pp 1422-1428, issn 0008-5472Article

Adriamycin resistance in human tumor cells associated with marked alterations in the regulation of the hexose monophosphate shunt and its response to oxidant stressCHAO YEH, G; OCCHIPINTI, S. J; COWAN, K. H et al.Cancer research (Baltimore). 1987, Vol 47, Num 22, pp 5994-5999, issn 0008-5472Article